Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 10
1984 16
1985 62
1986 108
1987 39
1988 49
1989 47
1990 53
1991 67
1992 53
1993 55
1994 42
1995 49
1996 43
1997 57
1998 39
1999 46
2000 30
2001 19
2002 31
2003 26
2004 39
2005 38
2006 38
2007 29
2008 29
2009 30
2010 27
2011 29
2012 30
2013 35
2014 22
2015 38
2016 46
2017 29
2018 41
2019 48
2020 76
2021 80
2022 68
2023 65
2024 33

Text availability

Article attribute

Article type

Publication date

Search Results

1,730 results

Results by year

Filters applied: . Clear all
Page 1
Carbapenems: past, present, and future.
Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Papp-Wallace KM, et al. Antimicrob Agents Chemother. 2011 Nov;55(11):4943-60. doi: 10.1128/AAC.00296-11. Epub 2011 Aug 22. Antimicrob Agents Chemother. 2011. PMID: 21859938 Free PMC article. Review.
We also highlight important features of the carbapenems that are presently in clinical use: imipenem-cilastatin, meropenem, ertapenem, doripenem, panipenem-betamipron, and biapenem. ...
We also highlight important features of the carbapenems that are presently in clinical use: imipenem-cilastatin, meropenem, er …
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms.
Tamma PD, Hsu AJ. Tamma PD, et al. J Pediatric Infect Dis Soc. 2019 Jul 1;8(3):251-260. doi: 10.1093/jpids/piz002. J Pediatric Infect Dis Soc. 2019. PMID: 30793757 Free PMC article. Review.
However, several beta-lactam agents with activity against carbapenem-resistant organisms were approved recently by the US Food and Drug Administration, and more are anticipated to be approved in the near future. ...
However, several beta-lactam agents with activity against carbapenem-resistant organisms were approved recently by the US Food and Drug …
The risk of seizures among the carbapenems: a meta-analysis.
Cannon JP, Lee TA, Clark NM, Setlak P, Grim SA. Cannon JP, et al. J Antimicrob Chemother. 2014 Aug;69(8):2043-55. doi: 10.1093/jac/dku111. Epub 2014 Apr 16. J Antimicrob Chemother. 2014. PMID: 24744302
OBJECTIVES: A consensus exists among clinicians that imipenem/cilastatin is the most epileptogenic carbapenem, despite inconsistencies in the literature. ...In studies directly comparing imipenem and meropenem, there was no difference in epileptogenicity in e …
OBJECTIVES: A consensus exists among clinicians that imipenem/cilastatin is the most epileptogenic carbapenem, despite inconsi …
Imipenem-cilastatin.
Dinsmoor MJ. Dinsmoor MJ. Obstet Gynecol Clin North Am. 1992 Sep;19(3):475-82. Obstet Gynecol Clin North Am. 1992. PMID: 1436925 Review.
Imipenem-cilastatin, with its broad spectrum of activity and relative safety, offers an excellent alternative for the treatment of many obstetric and gynecologic infections. ...Misuse and overuse of imipenem-cilastatin will result in the further develo …
Imipenem-cilastatin, with its broad spectrum of activity and relative safety, offers an excellent alternative for the treatmen …
Comparative review of imipenem/cilastatin versus meropenem.
Salmon-Rousseau A, Martins C, Blot M, Buisson M, Mahy S, Chavanet P, Piroth L. Salmon-Rousseau A, et al. Med Mal Infect. 2020 Jun;50(4):316-322. doi: 10.1016/j.medmal.2020.01.001. Epub 2020 Feb 5. Med Mal Infect. 2020. PMID: 32035719 Review.
INTRODUCTION: Carbapenems are broad-spectrum antibacterial molecules. Imipenem-cilastatin and meropenem are the two main molecules used in French healthcare services. ...RESULTS: Imipenem-cilastatin is the first marketed molecule of the carbapenem clas …
INTRODUCTION: Carbapenems are broad-spectrum antibacterial molecules. Imipenem-cilastatin and meropenem are the two main molec …
Clinical Pharmacokinetics and Pharmacodynamics of Imipenem-Cilastatin/Relebactam Combination Therapy.
McCarthy MW. McCarthy MW. Clin Pharmacokinet. 2020 May;59(5):567-573. doi: 10.1007/s40262-020-00865-3. Clin Pharmacokinet. 2020. PMID: 32009210 Review.
On 16 July, 2019, the US Food and Drug Administration approved imipenem-cilastatin/relebactam (Recarbrio) for the treatment of adults with complicated urinary tract infections and complicated intra-abdominal infections. ...This article provides an overview of …
On 16 July, 2019, the US Food and Drug Administration approved imipenem-cilastatin/relebactam (Recarbrio) for the treat …
Beneficial herb-drug interaction of rhein in Jinhongtang and Imipenem/Cilastatin mediated by organic anion transporters.
Wu F, Zhao T, Zhang Y, Wang Y, Liao G, Zhang B, Wang C, Tian X, Feng L, Fang B, Huo X, Ma X. Wu F, et al. J Ethnopharmacol. 2023 Aug 10;312:116449. doi: 10.1016/j.jep.2023.116449. Epub 2023 Apr 5. J Ethnopharmacol. 2023. PMID: 37023835
AIM OF THE STUDY: The present study aimed to explore the effect of Jinhongtang on the antibacterial activity of Imipenem/Cilastatin and to clarify the underlying mechanism of herb-drug interaction (HDI). ...However, MIC and MBC of Imipenem/Cilastati …
AIM OF THE STUDY: The present study aimed to explore the effect of Jinhongtang on the antibacterial activity of Imipenem/Cilastati …
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections.
Heo YA. Heo YA. Drugs. 2021 Feb;81(3):377-388. doi: 10.1007/s40265-021-01471-8. Epub 2021 Feb 25. Drugs. 2021. PMID: 33630278 Free PMC article. Review.
Imipenem/cilastatin/relebactam (Recarbrio) is an intravenously administered combination of the carbapenem imipenem, the renal dehydropeptidase-I inhibitor cilastatin, and the novel beta-lactamase inhibitor relebactam. ...It was also effective in …
Imipenem/cilastatin/relebactam (Recarbrio) is an intravenously administered combination of the carbapenem imipenem …
Unusual Drug Fever Caused by Imipenem/Cilastatin and a Review of Literature.
Yang J, Wang Q, Wang S, Zhang Y, Wang Z. Yang J, et al. Heart Surg Forum. 2019 Mar 8;22(2):E119-E123. doi: 10.1532/hsf.2141. Heart Surg Forum. 2019. PMID: 31013221 Review.
There are few previous reports about drug fever caused by imipenem/cilastatin. CASE PRESENTATION: Here, we described a 66-year-old man undergoing the Ivor Lewis esophagectomy for esophageal carcinoma, who developed drug fever. ...Body temperature incre …
There are few previous reports about drug fever caused by imipenem/cilastatin. CASE PRESENTATION: Here, we described a …
Imipenem/cilastatin-associated hiccups.
Lucena M, Andrade R, Cabello M, Clavijo E, Queipo de Llano E. Lucena M, et al. Ann Pharmacother. 1992 Nov;26(11):1459. doi: 10.1177/106002809202601125. Ann Pharmacother. 1992. PMID: 1477457 No abstract available.
1,730 results